New drug shortens administration time by 72% compared with the current therapy
One of the main issues for patients with cystic fibrosis is the high daily burden of treatment, which includes, among other procedures, nebulization, airway clearance therapy, and physical therapy.
Approximately two hours per day are dedicated specifically to the treatment of lung infections. To facilitate and expedite the treatment of these patients, the first antibiotic powder with a new therapeutic approach was launched in Brazil.
Source: Gaúcha ZH
